Skip to main content
Top
Published in: Trials 1/2014

Open Access 01-12-2014 | Study protocol

Effect of acupuncture treatment on vascular cognitive impairment without dementia: study protocol for a randomized controlled trial

Authors: Bo-Feng Yang, Xiang-Hong Zeng, Yan Liu, Qing-Nan Fu, Tian He, Fang Li, Guang-Xia Shi, Bao-Zhen Liu, San-Feng Sun, Jun Wang, Lei Xiao, Yan-Mei Deng, Cun-Zhi Liu

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

Vascular cognitive impairment, no dementia (VCIND) is a condition at risk for future dementia and should be the target of preventive strategies. Preliminary evidence suggests that acupuncture may be a clinically effective intervention for people with early-stage vascular cognitive impairment. We will do a multicenter, 6-month, drug-controlled, nonblinded, randomized, parallel-group trial to determine whether acupuncture is effective for improving cognitive function and quality of life for patients with VCIND.

Methods/Design

A total of 216 eligible patients will be recruited and randomly assigned acupuncture for two sessions/week (n = 108) or citicoline 300 mg/day (n = 108) in a multicenter, 6-month trial. The primary endpoint is cognition (Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-cog)). Secondary endpoints include assessments of activities of daily living and behavioral symptoms (Clock Drawing Test (CDT), Activities of Daily Living (ADL) and Instrumental Activities of Daily Living scale (IADL)).

Discussion

This will be the first large-scale trial specifically evaluating acupuncture therapy in VCIND. If the study confirms the effectiveness and safety of acupuncture treatment, it will be important to examine how the acupuncture approach could most effectively be integrated into the provision of routine healthcare.

Trial registration

This study is registered as an International Standard Randomised Controlled Trial on 17 January 2014, number ISRCTN82980206
Appendix
Available only for authorised users
Literature
1.
go back to reference O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST: Vascular cognitive impairment. Lancet Neurol. 2003, 2: 89-98. 10.1016/S1474-4422(03)00305-3.CrossRefPubMed O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST: Vascular cognitive impairment. Lancet Neurol. 2003, 2: 89-98. 10.1016/S1474-4422(03)00305-3.CrossRefPubMed
2.
3.
go back to reference Madureira S, Guerreiro M, Ferro JM: Dementia and cognitive impairment three months after stroke. Eur J Neurol. 2001, 6: 621-627.CrossRef Madureira S, Guerreiro M, Ferro JM: Dementia and cognitive impairment three months after stroke. Eur J Neurol. 2001, 6: 621-627.CrossRef
4.
go back to reference Tham W, Auchus AP, Thong M, Goh ML, Chang HM, Wong MC, Chen CP: Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporeanstroke patients. J Neurol Sci. 2002, 203–204: 49-52.CrossRefPubMed Tham W, Auchus AP, Thong M, Goh ML, Chang HM, Wong MC, Chen CP: Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporeanstroke patients. J Neurol Sci. 2002, 203–204: 49-52.CrossRefPubMed
5.
go back to reference Rasquin SM, Verhey FR, van Oostenbrugge RJ, Lousberg R, Lodder J: Demographic and CT scan features related to cognitive impairment in the first year after stroke. J Neurol Neurosurg Psychiatry. 2004, 75: 1562-1567. 10.1136/jnnp.2003.024190.CrossRefPubMedPubMedCentral Rasquin SM, Verhey FR, van Oostenbrugge RJ, Lousberg R, Lodder J: Demographic and CT scan features related to cognitive impairment in the first year after stroke. J Neurol Neurosurg Psychiatry. 2004, 75: 1562-1567. 10.1136/jnnp.2003.024190.CrossRefPubMedPubMedCentral
6.
go back to reference Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Østbye T, Wolfson C, Gauthier S, Verreault R, McDowell I: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001, 57: 714-716. 10.1212/WNL.57.4.714.CrossRefPubMed Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Østbye T, Wolfson C, Gauthier S, Verreault R, McDowell I: Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001, 57: 714-716. 10.1212/WNL.57.4.714.CrossRefPubMed
7.
go back to reference Chou P, Chu H, Lin JG: Effects of electroacupuncture treatment on impaired cognition and quality of life in Taiwanese stroke patients. J Altern Complement Med. 2009, 10: 1067-1073. Chou P, Chu H, Lin JG: Effects of electroacupuncture treatment on impaired cognition and quality of life in Taiwanese stroke patients. J Altern Complement Med. 2009, 10: 1067-1073.
8.
go back to reference Alvarez-Sabín J, Ortega G, Jacas C, Santamarina E, Maisterra O, Ribo M, Molina C, Quintana M, Román GC: Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovasc Dis. 2013, 35: 146-154. 10.1159/000346602.CrossRefPubMed Alvarez-Sabín J, Ortega G, Jacas C, Santamarina E, Maisterra O, Ribo M, Molina C, Quintana M, Román GC: Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovasc Dis. 2013, 35: 146-154. 10.1159/000346602.CrossRefPubMed
9.
go back to reference Wilcock G, Möbius HJ, Stöffler A, MMM 500 group: A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol. 2002, 6: 297-305.CrossRef Wilcock G, Möbius HJ, Stöffler A, MMM 500 group: A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol. 2002, 6: 297-305.CrossRef
10.
go back to reference Chu LW, Chiu KC, Hui SL, Yu GK, Tsui WJ, Lee PW: The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong. Ann Acad Med Singapore. 2000, 4: 474-485. Chu LW, Chiu KC, Hui SL, Yu GK, Tsui WJ, Lee PW: The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong. Ann Acad Med Singapore. 2000, 4: 474-485.
11.
go back to reference Schultz RR, Siviero MO, Bertolucci PH: The cognitive subscale of the "Alzheimer's Disease Assessment Scale" in a Brazilian sample. Braz J Med Biol Res. 2001, 34: 1295-1302. 10.1590/S0100-879X2001001000009.CrossRefPubMed Schultz RR, Siviero MO, Bertolucci PH: The cognitive subscale of the "Alzheimer's Disease Assessment Scale" in a Brazilian sample. Braz J Med Biol Res. 2001, 34: 1295-1302. 10.1590/S0100-879X2001001000009.CrossRefPubMed
12.
go back to reference Lamar M, Swenson R, Kaplan E, Libon DJ: Characterizing alterations in executive functioning across distinct subtypes of cortical and subcortical dementia. Clin Neuropsychol. 2004, 18: 22-31. 10.1080/13854040490507127.CrossRefPubMed Lamar M, Swenson R, Kaplan E, Libon DJ: Characterizing alterations in executive functioning across distinct subtypes of cortical and subcortical dementia. Clin Neuropsychol. 2004, 18: 22-31. 10.1080/13854040490507127.CrossRefPubMed
13.
go back to reference Peters R, Pinto EM: Predictive value of the Clock Drawing Test. A review of the literature. Dement Geriatr Cogn Disord. 2008, 26: 351-355. 10.1159/000162261.CrossRefPubMed Peters R, Pinto EM: Predictive value of the Clock Drawing Test. A review of the literature. Dement Geriatr Cogn Disord. 2008, 26: 351-355. 10.1159/000162261.CrossRefPubMed
14.
go back to reference Robinson DM, Keating GM: Memantine: a review of its use in Alzheimer's disease. Drugs. 2006, 66: 1515-1534. 10.2165/00003495-200666110-00015.CrossRefPubMed Robinson DM, Keating GM: Memantine: a review of its use in Alzheimer's disease. Drugs. 2006, 66: 1515-1534. 10.2165/00003495-200666110-00015.CrossRefPubMed
15.
go back to reference Spector WD, Fleishman JA: Combining activities of daily living with instrumental activities of daily living to measure functional disability. J Gerontol B Psychol Sci Soc Sci. 1998, 1: S46-S57.CrossRef Spector WD, Fleishman JA: Combining activities of daily living with instrumental activities of daily living to measure functional disability. J Gerontol B Psychol Sci Soc Sci. 1998, 1: S46-S57.CrossRef
16.
go back to reference Shi GX, Han LL, Liu LY, Li QQ, Liu CZ, Wang LP: Acupuncture at local and distant points for tinnitus: study protocol for a randomized controlled trial. Trials. 2012, 13: 224-10.1186/1745-6215-13-224.CrossRefPubMedPubMedCentral Shi GX, Han LL, Liu LY, Li QQ, Liu CZ, Wang LP: Acupuncture at local and distant points for tinnitus: study protocol for a randomized controlled trial. Trials. 2012, 13: 224-10.1186/1745-6215-13-224.CrossRefPubMedPubMedCentral
17.
go back to reference Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Lancet. 2002, 359: 1283-1290. 10.1016/S0140-6736(02)08267-3.CrossRefPubMed Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV: Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Lancet. 2002, 359: 1283-1290. 10.1016/S0140-6736(02)08267-3.CrossRefPubMed
18.
go back to reference Allam H, ElDine NG, Helmy G: Scalp acupuncture effect on language development in children with autism: a pilot study. J Altern Complement Med. 2008, 2: 109-114.CrossRef Allam H, ElDine NG, Helmy G: Scalp acupuncture effect on language development in children with autism: a pilot study. J Altern Complement Med. 2008, 2: 109-114.CrossRef
19.
go back to reference Smith T, Gildeh N, Holmes C: The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry. 2007, 52: 329-332.PubMed Smith T, Gildeh N, Holmes C: The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. Can J Psychiatry. 2007, 52: 329-332.PubMed
20.
go back to reference Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, Moberg PJ, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D: Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognitionaccording to mini-mental state examination score. J Am Geriatr Soc. 2009, 57: 304-308. 10.1111/j.1532-5415.2008.02096.x.CrossRefPubMed Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, Moberg PJ, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D: Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognitionaccording to mini-mental state examination score. J Am Geriatr Soc. 2009, 57: 304-308. 10.1111/j.1532-5415.2008.02096.x.CrossRefPubMed
21.
go back to reference Sikaroodi H, Yadegari S, Miri SR: Cognitive impairments in patients with cerebrovascular risk factors: a comparison of Mini Mental Status Exam and Montreal Cognitive Assessment. Clin Neurol Neurosurg. 2013, 115: 1276-1280. 10.1016/j.clineuro.2012.11.026.CrossRefPubMed Sikaroodi H, Yadegari S, Miri SR: Cognitive impairments in patients with cerebrovascular risk factors: a comparison of Mini Mental Status Exam and Montreal Cognitive Assessment. Clin Neurol Neurosurg. 2013, 115: 1276-1280. 10.1016/j.clineuro.2012.11.026.CrossRefPubMed
22.
go back to reference Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC: Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail. 2007, 9: 1003-1009. 10.1016/j.ejheart.2007.07.006.CrossRefPubMed Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC: Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail. 2007, 9: 1003-1009. 10.1016/j.ejheart.2007.07.006.CrossRefPubMed
23.
go back to reference Horstmann A, Frisch S, Jentzsch RT, Müller K, Villringer A, Schroeter ML: Resuscitating the heart but losing the brain: brain atrophy in the aftermath of cardiac arrest. Neurology. 2010, 74: 306-312. 10.1212/WNL.0b013e3181cbcd6f.CrossRefPubMed Horstmann A, Frisch S, Jentzsch RT, Müller K, Villringer A, Schroeter ML: Resuscitating the heart but losing the brain: brain atrophy in the aftermath of cardiac arrest. Neurology. 2010, 74: 306-312. 10.1212/WNL.0b013e3181cbcd6f.CrossRefPubMed
Metadata
Title
Effect of acupuncture treatment on vascular cognitive impairment without dementia: study protocol for a randomized controlled trial
Authors
Bo-Feng Yang
Xiang-Hong Zeng
Yan Liu
Qing-Nan Fu
Tian He
Fang Li
Guang-Xia Shi
Bao-Zhen Liu
San-Feng Sun
Jun Wang
Lei Xiao
Yan-Mei Deng
Cun-Zhi Liu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-442

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue